← back to search

Enrique A. Mesri

University of Miami · US
Area of research
Oncology · Epidemiology
Research interest
Research interests include Viral-associated cancers and disorders, Cytomegalovirus and herpesvirus research, Lymphoma Diagnosis and Treatment, and Histiocytic Disorders and Treatments.
h-index
34
citations
7,317
works
88
NIH funding
primary concept
email

Recent publications

Unveiling the role of KSHV‐infected human mesenchymal stem cells in Kaposi's sarcoma initiation
Journal of Medical Virology 2024cited by 10position: middledoi
The Kaposi’s sarcoma progenitor enigma: KSHV-induced MEndT–EndMT axis
Trends in Molecular Medicine 2023cited by 20position: lastdoi
Oral and anal microbiome from HIV-exposed individuals: role of host-associated factors in taxa composition and metabolic pathways
npj Biofilms and Microbiomes 2023cited by 17position: middledoi
2‐Deoxy‐<scp>d</scp>‐glucose exploits increased glucose metabolism in cancer and viral‐infected cells: Relevance to its use in <scp>India</scp> against <scp>SARS‐CoV</scp>‐2
IUBMB Life 2021cited by 28position: firstdoi
Kaposi’s sarcoma herpesvirus activates the hypoxia response to usurp HIF2α-dependent translation initiation for replication and oncogenesis
Cell Reports 2021cited by 16position: lastdoi
A Non-Coding RNA Network Involved in KSHV Tumorigenesis
Frontiers in Oncology 2021cited by 14position: middledoi
KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi’s sarcoma
PLoS Pathogens 2020cited by 19position: middledoi
High-throughput sequencing analysis of a “hit and run” cell and animal model of KSHV tumorigenesis
PLoS Pathogens 2020cited by 18position: lastdoi
PDGFRA defines the mesenchymal stem cell Kaposi’s sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment
PLoS Pathogens 2019cited by 33position: lastdoi
A role of hypoxia-inducible factor 1 alpha in Murine Gammaherpesvirus 68 (MHV68) lytic replication and reactivation from latency
PLoS Pathogens 2019cited by 21position: middledoi
KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis
PLoS Pathogens 2018cited by 40position: lastdoi
Human Viral Oncogenesis: A Cancer Hallmarks Analysis
Cell Host & Microbe 2014cited by 637position: firstdoi
Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
Cell 2014cited by 496position: middledoi
Molecular and Cellular Mechanisms of KSHV Oncogenesis of Kaposi's Sarcoma Associated with HIV/AIDS
PLoS Pathogens 2014cited by 107position: lastdoi
Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway
Oncogene 2014cited by 84position: middledoi
CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma
Blood 2013cited by 83position: middledoi
Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma
Journal of Clinical Investigation 2013cited by 70position: middledoi
Molecular studies and therapeutic targeting of Kaposi’s sarcoma herpesvirus (KSHV/HHV-8) oncogenesis
Immunologic Research 2013cited by 15position: firstdoi
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma
The Journal of Experimental Medicine 2012cited by 196position: middledoi
A Role for Virally Induced Reactive Oxygen Species in Kaposi's Sarcoma Herpesvirus Tumorigenesis
Antioxidants and Redox Signaling 2012cited by 64position: lastdoi
Activation of the Unfolded Protein Response by 2-Deoxy- <scp>d</scp> -Glucose Inhibits Kaposi's Sarcoma-Associated Herpesvirus Replication and Gene Expression
Antimicrobial Agents and Chemotherapy 2012cited by 59position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Julián Naipauer · Consejo Nacional de Investigaciones Científicas y Técnicas9 papers (2014–2024)Lucas E. Cavallin · University of Miami6 papers (2012–2020)Pascal J. Goldschmidt‐Clermont · University of Miami5 papers (2012–2019)Martı́n C. Abba · University of Miami5 papers (2019–2024)Qi Ma · Tianjin University of Science and Technology4 papers (2012–2020)Siôn L. Williams · APLA Health4 papers (2019–2023)Howard J. Leung · Universidad Autónoma de Madrid4 papers (2012–2013)Omar A. Coso · Consejo Nacional de Investigaciones Científicas y Técnicas4 papers (2020–2024)Ezequiel Lacunza · Centro Científico Tecnológico - San Juan3 papers (2021–2024)Daria Salyakina · Flatiron Health (United States)3 papers (2019–2021)Santas Rosario · University of Miami3 papers (2019–2021)Brittany M. Ashlock · Sylvester Comprehensive Cancer Center3 papers (2013–2013)Ethel Cesarman · Cornell University3 papers (2020–2024) · 2 papers (2012–2014)Joshua M. Hare · University of Miami2 papers (2019–2021)Juan Carlos Ramos · Palmetto Hematology Oncology2 papers (2013–2013)Sachin Gupta · Sher-e-Kashmir University of Agricultural Sciences and Technology of Jammu2 papers (2018–2019) · 2 papers (2012–2014)Margaret A. Shipp · Harvard University2 papers (2012–2014) · 2 papers (2012–2014)